Shanneil Guzman
Family · Washington, DCNPI 1912744343
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,226 of the $1,594 with a category attached, or 76.9%. It is spread thinly across 29 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations.
Across 51 payments — averaging $31.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$169
- Incyte Corporation$157
- Novartis$152
- Sobi, Inc$118
- E.r. Squibb & Sons, L.L.C.$110
- Gilead$93
- plus $796 from 23 others
What the payments were for
- Food & beverage$1,22677%
- Education$36823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $169 |
| Incyte Corporation | 4 | $157 |
| Novartis | 6 | $152 |
| Sobi, Inc | 3 | $118 |
| E.r. Squibb & Sons, L.L.C. | 1 | $110 |
| Gilead | 1 | $93 |
| AbbVie | 3 | $72 |
| Bayer | 2 | $56 |
| Pfizer | 2 | $55 |
| Merck | 2 | $52 |
| Tersera Therapeutics LLC | 2 | $49 |
| Beone Medicines USA, Inc. | 2 | $46 |
| Eisai Inc. | 2 | $41 |
| Taiho Oncology, Inc. | 2 | $38 |
| Exelixis Inc. | 1 | $33 |
| Pharmaessentia USA Corporation | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Legend Biotech USA Inc. | 1 | $26 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| ADC Therapeutics America, Inc. | 1 | $25 |
| Novocure Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Spectrum Pharmaceuticals Inc. | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Accord Healthcare, Inc. | 1 | $17 |
How this compares
$1,594 in reported general payments places this provider in the 85th percentile of 392 family providers in District of Columbia.
Other family in Washington
- Amy StewartWashington$489K
- Kara CouchWashington$144K
- Laura XandersWashington$109K
- Laura MackeWashington$39K
- Cassandra ThompsonWashington$11K
- Sharmin DiazWashington$9K
- Emily BertrandWashington$8K
- Ana Carrion-GelabertWashington$7K
- Chanda CopelandWashington$7K
- Suad NsouliWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.